Nautilus Biotechnology Inc (NAUT)
NASDAQ
News
Market Data
Register for real-time alerts, custom portfolio, and market movers
The current NAUT market cap is 260.07M. The company's latest EPS is USD -0.6782 and P/E is -4.08.
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | ||
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -18.06M | -19.02M | -19.08M | -20M | -21.61M |
| Net Income | -14.97M | -15.81M | -15.88M | -17.02M | -18.73M |
| Year End December 30 2023 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 0 | 0 | 0 | 0 |
| Operating Income | -576k | -50.5M | -63.62M | -76.15M |
| Net Income | -523k | -50.32M | -57.92M | -63.68M |
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | ||
| Total Assets | 345.88M | 330.77M | 318.34M | 305.57M | 288.65M |
| Total Liabilities | 42.17M | 41.09M | 41.06M | 40.21M | 39.16M |
| Total Equity | 303.72M | 289.67M | 277.27M | 265.35M | 249.49M |
| Year End December 30 2023 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 150.86M | 398.45M | 350.05M | 305.57M |
| Total Liabilities | 5.62M | 34.87M | 35.13M | 40.21M |
| Total Equity | 5M | 363.58M | 314.92M | 265.35M |
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | ||
| Operating | -12.52M | -26.07M | -37.81M | -51.71M | -16.27M |
| Investing | -13.5M | -15.75M | -2.68M | -43.74M | 22.35M |
| Financing | 1,000 | 99k | 115k | 368k | 245k |
| Year End December 30 2023 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -549k | -39.24M | -45.81M | -51.71M |
| Investing | -149.5M | -138.96M | -25.74M | -43.74M |
| Financing | 151.05M | 327.45M | 562k | 368k |
| Market Cap | 260.07M |
| Price to Earnings Ratio | -4.08 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 13.41 |
| Price to Book Ratio | 0.98 |
| Dividend Yield | - |
| Shares Outstanding | 93.89M |
| Average Volume (1 week) | 48.06k |
| Average Volume (1 Month) | 69.24k |
| 52 Week Change | -12.34% |
| 52 Week High | 4.00 |
| 52 Week Low | 2.19 |
| Spread (Intraday) | 0.35 (12.24%) |
| Company Name | Nautilus Biotechnology Inc |
| Address |
corporation trust center wilmington, delaware 19801 |
| Website | https://www.nautilus.bio |
| Industry | lab analytical instruments (3826) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
